Latest News and Press Releases

SERB Pharmaceuticals has completed the acquisition of development and commercialization rights to Idefirix (imlifidase) in Europe

ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has launched a series of new resources for kidney transplant patients and their loved ones that explains the complex...

Clinical Phase II milestone: All 63 donor-recipient pairs enrolled and treated according to protocol across multiple clinical centers

Eledon Presents Long-Term Phase 2 BESTOW Results at ATC Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart

ROCKVILLE, Md., June 09, 2026 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announced the launch of FSGS in Focus, a national education awareness campaign to increase patient and...

Synklino announces treatment of first patient in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation. 

ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announced a significant expansion of its Kidney Health Coach® (KHC) community health education program,...

Eledon to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at ATC

SERB Pharmaceuticals to acquire development and commercialisation rights to Idefirix® (imlifidase) in Europe and MENA from Hansa Biopharma for €115 million

ROCKVILLE, Md., May 18, 2026 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) announced today that it is launching a two-year, quarterly professional education curriculum for interdisciplinary...